Detalhe da pesquisa
1.
ARNT-dependent CCR8 reprogrammed LDH isoform expression correlates with poor clinical outcomes of prostate cancer.
Mol Carcinog
; 59(8): 897-907, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32319143
2.
Correction to: MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer.
Mol Cancer
; 18(1): 122, 2019 Aug 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31387585
3.
Expression of PD-L1 in tumor-associated nerves correlates with reduced CD8+ tumor-associated lymphocytes and poor prognosis in prostate cancer.
Int J Cancer
; 144(12): 3099-3110, 2019 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30537104
4.
Retraction Note: MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer.
Mol Cancer
; 22(1): 56, 2023 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36941584
5.
MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer.
Mol Cancer
; 16(1): 48, 2017 02 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-28241827
6.
Expression of SOCSs in human prostate cancer and their association in prognosis.
Mol Cell Biochem
; 381(1-2): 51-9, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23666742
7.
Down-regulation of the ErbB3 binding protein 1 in human bladder cancer promotes tumor progression and cell proliferation.
Mol Biol Rep
; 40(5): 3799-805, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23283744
8.
Tumor Suppressor Role and Clinical Significance of the FEV Gene in Prostate Cancer.
Dis Markers
; 2022: 8724035, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35548776
9.
TRIB1 induces macrophages to M2 phenotype by inhibiting IKB-zeta in prostate cancer.
Cell Signal
; 59: 152-162, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30926388
10.
Expression and Clinical Significance of SOX9 in Renal Cell Carcinoma, Bladder Cancer and Penile Cancer.
Oncol Res Treat
; 40(1-2): 15-20, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28118628
11.
High expression of ASPM correlates with tumor progression and predicts poor outcome in patients with prostate cancer.
Int Urol Nephrol
; 49(5): 817-823, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28213802
12.
E2F1 promotes tumor cell invasion and migration through regulating CD147 in prostate cancer.
Int J Oncol
; 48(4): 1650-8, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26891801
13.
Aberrant hypomethylation-mediated CD147 overexpression promotes aggressive tumor progression in human prostate cancer.
Oncol Rep
; 33(5): 2648-54, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25813864
14.
CC chemokine ligand 18 correlates with malignant progression of prostate cancer.
Biomed Res Int
; 2014: 230183, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25197632
15.
An integrative proteomics and interaction network-based classifier for prostate cancer diagnosis.
PLoS One
; 8(5): e63941, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23737958